144 related articles for article (PubMed ID: 38032244)
1. Focal fatty sparing areas of the pediatric steatotic liver: pseudolesions on hepatobiliary phase magnetic resonance images.
Özer G; Özcan HN; Oğuz B; Haliloğlu M
Diagn Interv Radiol; 2024 Mar; 30(2):135-138. PubMed ID: 38032244
[TBL] [Abstract][Full Text] [Related]
2. Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI.
Ünal E; İdilman İS; Karaosmanoğlu AD; Özmen MN; Akata D; Karcaaltıncaba M
Diagn Interv Radiol; 2019 Nov; 25(6):416-420. PubMed ID: 31650968
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
[TBL] [Abstract][Full Text] [Related]
4. Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
Kim PH; Hwang JY; Choi YH; Yoon HM; Lee CW
Radiology; 2024 Jun; 311(3):e232462. PubMed ID: 38860893
[TBL] [Abstract][Full Text] [Related]
5. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
7. Focal sparing of iron and fat in liver tissue in patients with hemosiderosis: diagnosis with combination of R2* relaxometry and proton density fat fraction calculation by MRI.
Karçaaltincaba M; Idilman I; Celik A
Diagn Interv Radiol; 2011 Dec; 17(4):323-7. PubMed ID: 21267943
[TBL] [Abstract][Full Text] [Related]
8. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
Kim MJ; Rhee HJ; Jeong HT
AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
10. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
Taibbi A; Brancatelli G; Matranga D; Midiri M; Lagalla R; Bartolotta TV
Diagn Interv Radiol; 2019 Mar; 25(2):95-101. PubMed ID: 30860073
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.
Vernuccio F; Gagliano DS; Cannella R; Ba-Ssalamah A; Tang A; Brancatelli G
Insights Imaging; 2021 Jan; 12(1):8. PubMed ID: 33432491
[TBL] [Abstract][Full Text] [Related]
16. Imaging features of hepatic inflammatory pseudotumor: distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging.
Ichikawa S; Motosugi U; Suzuki T; Shimizu T; Onishi H
Abdom Radiol (NY); 2020 Aug; 45(8):2400-2408. PubMed ID: 32468212
[TBL] [Abstract][Full Text] [Related]
17. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
[TBL] [Abstract][Full Text] [Related]
18. Confident non-invasive diagnosis of pseudolesions of the liver using diffusion-weighted imaging at 3T MRI.
Fruehwald-Pallamar J; Bastati-Huber N; Fakhrai N; Jantsch M; Puchner S; Herneth AM; Ba-Ssalamah A
Eur J Radiol; 2012 Jun; 81(6):1353-9. PubMed ID: 21507591
[TBL] [Abstract][Full Text] [Related]
19. Non-focal liver signal abnormalities on hepatobiliary phase of gadoxetate disodium-enhanced MR imaging: a review and differential diagnosis.
Furlan A; Borhani AA; Heller MT; Yu RK; Tublin ME
Abdom Radiol (NY); 2016 Jul; 41(7):1399-410. PubMed ID: 26907715
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
